Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 3Unknown 2Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Breast 3

Conditions

Breast Neoplasms 3Neoplasms 2Colorectal Neoplasms 2Rectal Neoplasms 1Esophageal Neoplasms 1Epilepsy 1Carcinoma, Transitional Cell 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Lobular 1

Interventions

Trastuzumab 351Paclitaxel 334Cyclophosphamide 315Docetaxel 292Capecitabine 181Doxorubicin 180Letrozole 165Tamoxifen 145Bevacizumab 124Fulvestrant 118Carboplatin 118exemestane 111Lapatinib 111Anastrozole 111Radiotherapy 105Epirubicin 104Gemcitabine 97palbociclib 83Exercise 78Vinorelbine 77Fluorouracil 77Surveys and Questionnaires 71pertuzumab 68Filgrastim 64Albumin-Bound Paclitaxel 64Magnetic Resonance Spectroscopy 56eribulin 55Everolimus 52Blood Specimen Collection 51Zoledronic Acid 50

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Breast Neoplasms × Histocompatibility Testing × Clear all
NCT07023822 2026-05-05

WISH, Feasibility of a Factorial Design

The University of Tennessee, Knoxville

Phase NA Completed
18 enrolled
Breast

Breast Neoplasms

NCT00581750 2021-07-02

Molecular Genetic Basis of Invasive Breast Cancer Risk Associated With Lobular Carcinoma in Situ

Memorial Sloan Kettering Cancer Center

Completed
550 enrolled
Breast

Breast Neoplasms, Carcinoma, Lobular

NCT01271738 2015-08-17

Evaluating and Comparing Two Surgical Methods for Treatment of Early Stage Breast Cancer

Emory University

Phase NA Completed
79 enrolled
Breast

Breast Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡